Advanced targeted nanomedicine.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Biotechnology

• Publication date

  2015-05-20

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.jbiotec.2015.01.009PMID 25615945PMCID PMC4685670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bhasma : The ancient Indian nanomedicine

  2014cited by this paper
• Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment

  2014cited by this paper
• Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer

  2014cited by this paper
• Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery.

  2014cited by this paper
• Antiproliferative effect of pHLIP-amanitin.

  2013cited by this paper
• Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.

  2013cited by this paper
• pH‐Controlled Delivery of Nanoparticles into Tumor Cells

  2013cited by this paper
• Focused ultrasound mediated drug delivery from temperature-sensitive liposomes: in-vitro characterization and validation

  2013cited by this paper
• Family of pH (low) insertion peptides for tumor targeting

  2013influential reference
• (18)F-labeled-bioorthogonal liposomes for in vivo targeting.

  2013cited by this paper
• Stimuli-responsive nanocarriers for drug delivery.

  2013cited by this paper
• A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery.

  2013cited by this paper
• pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis

  2013cited by this paper
• pHLIP®-mediated delivery of PEGylated liposomes to cancer cells.

  2013influential reference
• Tumour heterogeneity and cancer cell plasticity

  2013cited by this paper
• Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress

  2013cited by this paper
• KDEL peptide gold nanoconstructs: promising nanoplatforms for drug delivery.

  2013cited by this paper
• Targeting diseased tissues by pHLIP insertion at low cell surface pH

  2013cited by this paper
• Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment

  2013cited by this paper
• In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles.

  2013cited by this paper
• Nanoparticle delivery of cancer drugs.

  2012cited by this paper
• Thermosensitive polymeric hydrogels as drug delivery systems.

  2012cited by this paper
• Temperature-sensitive polymers for drug delivery

  2012cited by this paper
• Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery.

  2012cited by this paper
• Cellular transport pathways of polymer coated gold nanoparticles.

  2012cited by this paper
• Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia

  2012cited by this paper
• pHLIP peptide targets nanogold particles to tumors

  2012influential reference
• Nanoparticles for Targeted and Temporally Controlled Drug Delivery

  2012cited by this paper
• Nanoparticles as computed tomography contrast agents: current status and future perspectives.

  2012cited by this paper
• Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking.

  2012cited by this paper
• Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation.

  2012cited by this paper
• Gold-doxorubicin nanoconjugates for overcoming multidrug resistance.

  2012cited by this paper
• pH-controlled delivery of luminescent europium coated nanoparticles into platelets

  2012cited by this paper
• Gold-peptide nanoconjugate cellular uptake is modulated by serum proteins.

  2012cited by this paper
• Colloidal stability of gold nanoparticles modified with thiol compounds: bioconjugation and application in cancer cell imaging.

  2012cited by this paper
• pH (low) insertion peptide (pHLIP) targets ischemic myocardium

  2012influential reference
• Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy.

  2012cited by this paper
• Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research

  2012cited by this paper
• Influence of nanotechnology on herbal drugs: A Review

  2012cited by this paper
• In Vivo pH Imaging with 99mTc-pHLIP

  2012cited by this paper
• Modulation of the pHLIP transmembrane helix insertion pathway.

  2012cited by this paper
• Magnetic-plasmonic nanoparticles for the life sciences: calculated optical properties of hybrid structures.

  2012cited by this paper
• Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo.

  2012cited by this paper
• Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.

  2011cited by this paper
• Modeling nanophotothermal therapy: kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles.

  2011cited by this paper
• Measuring Tumor Aggressiveness and Targeting Metastatic Lesions with Fluorescent pHLIP

  2011cited by this paper
• Early drug discovery and the rise of pharmaceutical chemistry.

  2011cited by this paper
• Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.

  2011cited by this paper
• Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice

  2011cited by this paper
• PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.

  2011cited by this paper
• Targeting hypoxia in cancer therapy

  2011cited by this paper
• Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.

  2011cited by this paper
• Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide.

  2011cited by this paper
• Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia.

  2011cited by this paper
• Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20.

  2011cited by this paper
• Drug resistance and cellular adaptation to tumor acidic pH microenvironment.

  2011cited by this paper
• Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping.

  2011cited by this paper
• Roles of carboxyl groups in the transmembrane insertion of peptides.

  2011cited by this paper
• Developmental and pathological angiogenesis.

  2011cited by this paper
• Gold nanotags for combined multi-colored Raman spectroscopy and x-ray computed tomography

  2010cited by this paper
• Triggered drug delivery from biomaterials

  2010cited by this paper
• pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path

  2010cited by this paper
• X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer

  2010cited by this paper
• Strategies in the design of nanoparticles for therapeutic applications

  2010cited by this paper
• Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications

  2010cited by this paper
• Physicochemical characterization of Ayurvedic bhasma (Swarna makshika bhasma): An approach to standardization

  2010cited by this paper
• pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation

  2010cited by this paper
• Nanotechnology in drug delivery and tissue engineering: from discovery to applications.

  2010cited by this paper
• Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x-ray computed tomography.

  2010cited by this paper
• Passive and active drug targeting: drug delivery to tumors as an example.

  2010cited by this paper
• Self‐Assembled pH‐Sensitive Nanoparticles: A Platform for Oral Delivery of Protein Drugs

  2010cited by this paper
• Heparin-coated gold nanoparticles for liver-specific CT imaging.

  2009cited by this paper
• Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer

  2009cited by this paper
• Targeting the hypoxia-inducible factor (HIF) pathway in cancer

  2009cited by this paper
• A novel technology for the imaging of acidic prostate tumors by positron emission tomography.

  2009cited by this paper
• pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model.

  2009cited by this paper
• pHLIP-mediated translocation of membrane-impermeable molecules into cells.

  2009cited by this paper
• Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.

  2009cited by this paper
• Protracted elimination of gold nanoparticles from mouse liver.

  2009cited by this paper
• The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis

  2009cited by this paper
• Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles.

  2009cited by this paper
• Active targeting schemes for nanoparticle systems in cancer therapeutics.

  2008cited by this paper
• Biofunctionalized targeted nanoparticles for therapeutic applications

  2008cited by this paper
• Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.

  2008cited by this paper
• Nanoparticles in Medicine: Therapeutic Applications and Developments

  2008cited by this paper
• Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue

  2008cited by this paper
• A microenvironmental model of carcinogenesis

  2008cited by this paper
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008cited by this paper
• Magnetic nanoparticles for gene and drug delivery

  2008cited by this paper
• Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane

  2008cited by this paper
• Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

  2007cited by this paper
• Overview of resistance to systemic therapy in patients with breast cancer.

  2007cited by this paper
• Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery.

  2007cited by this paper
• Breast cancer chemosensitivity

  2007cited by this paper
• pH‐Sensitive liposomes‐principle and application in cancer therapy

  2007cited by this paper
• Hypoxia and cancer

  2007cited by this paper
• Annual review of cell and developmental biology.

  2007cited by this paper
• Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications.

  2007cited by this paper
• Lipid-based Nanoparticles for Nucleic Acid Delivery

  2007cited by this paper
• A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers.

  2007cited by this paper

• From detection to intervention: nanotechnology-driven precision strategies in obesity management

  2026cites this paper
• Nano-Reagents in Acute Pancreatitis: Diagnostic, Therapeutic, and Theranostic Advances.

  2026cites this paper
• Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine

  2024cites this paper
• Red blood cells based nanotheranostics: A smart biomimetic approach for fighting against cancer.

  2024cites this paper
• Molecular Beamforming for Actuation in Molecular Communication Networks

  2023cites this paper
• Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor

  2023cites this paper
• Conjugated Nanoparticles for Solid Tumor Theranostics: Unraveling the Interplay of Known and Unknown Factors

  2023cites this paper
• The role of protein corona on nanodrugs for organ-targeting and its prospects of application.

  2023cites this paper
• Kinetics of pHLIP peptide insertion into and exit from a Kinetics of pHLIP peptide insertion into and exit from a membrane membrane

  2023cites this paper
• The Promise of Nanotechnology in Personalized Medicine

  2022cites this paper
• Active targeting of CD4+ T lymphocytes by PEI-capped, peptide-functionalized gold nanoparticles

  2022cites this paper
• Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer

  2022cites this paper
• Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives

  2021cites this paper
• Evolution Towards Theranostics: Basic Principles

  2021cites this paper
• Preclinical Evaluation of Polymeric Nanocomposite Containing Pregabalin for Sustained Release as Potential Therapy for Neuropathic Pain

  2021cites this paper
• Investigating MTX-Loaded magnetic nanocomposite particles for treatment of rheumatoid arthritis

  2020cites this paper
• Nanomedicines and Nanodrug Delivery Systems: Trends and Perspectives

  2020cites this paper
• PHYSICAL CHARACTERIZATION OF WARBURG EFFECT IN CANCER CELLS

  2020cites this paper
• Synthesis, characterization and kinetic study of silver and gold nanoparticles produced by the archaeon Haloferax volcanii

  2020cites this paper
• Kinetics of pHLIP peptide insertion into and exit from a membrane

  2020cites this paper
• Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding

  2020cites this paper
• Recent practices of medicinal and aromatic plants in nanotechnology

  2020cites this paper
• Nanocarriers as Magic Bullets in the Treatment of Leukemia

  2020cites this paper
• Controlled drug release from polyelectrolyte-drug conjugate nanoparticles.

  2020cites this paper
• Non-Uniform BCSK Modulation in Nutrient-Limited Relay-Assisted Molecular Communication System: Optimization and Performance Evaluation.

  2019cites this paper
• End-to-End Performance Optimization in Hybrid Molecular and Electromagnetic Communications

  2019cites this paper
• Influence of different stabilizers on the morphology of gold nanoparticles

  2019cites this paper
• Non-Uniform BCSK Modulation in Nutrient Limited Molecular Communication System: Optimization and Performance Evaluation

  2019cites this paper
• Biosynthesis, characterization, and anticancer effect of plant-mediated silver nanoparticles using Coptis chinensis

  2019cites this paper
• Epigenetics in cancer therapy and nanomedicine

  2019cites this paper
• Multiple-Type Transmission Multiple-Type Reception Framework on Molecular Communication

  2019cites this paper
• How to kill cancer: starve it and shoot it

  2019cites this paper
• Immobilization of a pH-low insertion peptide onto SiO2/aminosilane-coated magnetite nanoparticles

  2019cites this paper
• Gold Nanoparticles to Tackle Drug Resistance in Cancer

  2019cites this paper
• Molecular Mechanism of Polypeptide Insertion into Bilayer and Exit

  2018cites this paper
• Formulation of ceftriaxone conjugated gold nanoparticles and their medical applications against extended-spectrum β-Lactamase producing bacteria and breast cancer.

  2018cites this paper
• Gold nanoparticles for nanotheranostics in leukemia – Addressing Chronic Myeloid Leukemia

  2018cites this paper
• Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond

  2018cites this paper
• Lipid Nanocarriers for Intracellular Delivery

  2018cites this paper
• Fine tuning neuronal targeting of nanoparticles by adjusting the ligand grafting density and combining PEG spacers of different length.

  2018cites this paper
• Personalized Nanomedicine: A Revolution at the Nanoscale

  2017influential citation
• pH- and temperature-responsive nanosystems

  2017cites this paper
• Applications of pHLIP Technology for Cancer Imaging and Therapy.

  2017cites this paper
• Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer

  2017cites this paper
• Atomic Force Microscopy as a Tool to Assess the Specificity of Targeted Nanoparticles in Biological Models of High Complexity

  2017cites this paper
• Folic acid and trastuzumab conjugated redox responsive random multiblock copolymeric nanocarriers for breast cancer therapy: In-vitro and in-vivo studies.

  2017cites this paper
• Identification of a nanobody specific to human pulmonary surfactant protein A

  2017cites this paper
• Targeted cancer therapy through antibody fragments‐decorated nanomedicines

  2017cites this paper
• The influence of surface charge on serum protein interaction and cellular uptake: studies with dendritic polyglycerols and dendritic polyglycerol-coated gold nanoparticles

  2017cites this paper
• Legomedicine—A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates

  2017cites this paper
• Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer

  2017cites this paper
• Tumor Microenvironment Responsive ACPP‐Conjugated Micelles for Targeted Treatment of Brain Glioma

  2017cites this paper
• Nano-enabled disulfiram for cancer therapy

  2017cites this paper
• Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery.

  2016cites this paper
• Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin

  2016cites this paper
• Phage Peptide Libraries As a Source of Targeted Ligands

  2016cites this paper
• Effect of Polyethyleneimine Stabilizer on Size and Morphology of Gold Nanoparticles

  2016cites this paper
• Cancer nanotheranostics: Strategies, promises and impediments.

  2016cites this paper
• pHLIP-modified magnetic nanoparticles for targeting acidic diseased tissue

  2016cites this paper
• pH-sensitive pHLIP® coated niosomes

  2016cites this paper
• Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma

  2016cites this paper
• Corrigendum to "Advanced targeted nanomedicine" [J. Biotechnol. 202 (2015) 88-97].

  2016cites this paper
• Receptor-Meditated Endocytosis by Hyaluronic Acid@Superparamagnetic Nanovetor for Targeting of CD44-Overexpressing Tumor Cells

  2016cites this paper
• Nanotechnology and Pediatric Cancer: Prevention, Diagnosis and Treatment

  2015cites this paper
• Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery

  2015cites this paper
• Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?

  2015cites this paper
• Pharmacological agents and transport nanosystems based on plant phospholipids

  2015cites this paper